MedPath

A randomized, controlled, patient- and assessor- blinded, exploratory clinical trial to search the stimulation site for repetitive transcranial magnetic stimulation (rTMS) that improves upper extremity function after stroke

Not Applicable
Recruiting
Conditions
Diseases of the circulatory system
Registration Number
KCT0008496
Lead Sponsor
Ministry of Science and ICT
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

1) Adults over 20 years of age
2) Patients more than 3 months after onset of stroke
3) Patients with NIHSS score of 1 or more to 20 or less
4) After receiving a detailed explanation of the study and fully understanding it, the subject has voluntarily decided to participate and has given written consent to comply with the precautions.

Exclusion Criteria

1) Patients with systemic infectious symptoms at the time of participation in clinical trials
2) In the case of a person with impaired consent (less than 10 points on the MMSE), who is not accompanied by a guardian
3) Those with severe medical conditions such as cardiovascular system, digestive system, respiratory system, endocrine system, etc.
4) Other cases where the researcher judges that participation in this clinical trial is not appropriate
5) Those who are contraindicated for repetitive transcranial magnetic stimulation
A. In the case of metal substances (deep brain stimulation electrodes, cerebral aneurysm clips, cardiac pacemakers, etc.)
B. Patients with uncontrolled epilepsy (epilepsy) or mental illness
6) Pregnant, lactating women and patients who may become pregnant
7) Patients with contraindications to imaging
8) Those who have undergone cerebral surgery with past or current medical history

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison between the two groups of FMA (Fugl-Meyer Assessment) change values 3 months after rTMS compared to the initial test
Secondary Outcome Measures
NameTimeMethod
Comparison of the change values of the two groups after 3 months of rTMS compared to the initial test - Comparison List: ROM (Range of Motion), BBS (Berg Balance Scale), MAS (Motor Assessment Scale), TIS (Tremble Imbalance Scale), FAC (Functional Gait Category), TUG (Time Up and Go), MMT (Passive Strength) test), ARAT(Action Reach Arm Test), Jebsen Taylor hand function test, FIM(Functional Independence Measure), MBI(Modified Barthel index), NIHSS(NIHSS(National Institutes of Health stroke scale)), K-MMSE(Korean Mini -Mental State Examination) ), CDR (Clinical Dementia Grade), GDS (Global Deterioration Scale), GDS Depression (Geriatric Depression Scale), Brain fMRI [Examination Group B patients only], EEG, Evoked Potential Test, MI Hematology Motricity index
© Copyright 2025. All Rights Reserved by MedPath